Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Comment by Colwrllon Jan 22, 2017 12:44am
420 Views
Post# 25738228

RE:RE:RE:RE:RE:RE:Expectations

RE:RE:RE:RE:RE:RE:Expectations

Another thing to factor in (referring to Berta's point about APH and CGC not having the largest bumps due to their license) is the much, much greater knowledge of the investor pool. 

Arguably, before November 2016, I'd say well over 50% of today's investors had no clue about this industry and if they did, they chuckled at the thought of its legality. My friends laughed when I told them I bought a cannabis stock in 2014 (bedrocan at 80 cents), until I let them know 2 years later I sold CGC for an 850% increase in late november.

Now its not just smart money, its your large investment banks and average joe investor who are anxiously scouring the internet for clues to the next piece of news that will send a green stock rising.

Those clues in the month of December were licenses. Case in point, look at EMC when there's was announced (so much for it reaching my limit buy at $2.50). 

So although I don't think this will soar like EMC's did, I would not be surprised to see this in the $3's by midweek. 

Just my two cents. 

Bullboard Posts